Psyence Biomedical Ltd. (PBM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Psyence Biomedical Ltd. (PBM) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PBM Income Statement

Psyence Biomedical Ltd. (PBM) annual income statement — 5-year revenue, gross profit & net income history

Metric	Q2'25	Q2'24	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	1.33K	1.02K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-1.33K	-1.02K	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-30.91%	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	1.5M	1.16M	632.1K	754.38K	512.09K	771.49K	1.74M	-281.46K	293.02K	326.9K	254.79K	45.06K
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	1.15M	890.48K	556.97K	184.7K	512.09K	771.49K	762.74K	242.15K	293.02K	326.9K	254.79K	45.06K
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	357.44K	265.63K	75.14K	0	0	0	977.92K	1.85K	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	1.02K	0	569.67K	0	0	0	-525.46K	0	0	0	0
Operating Income	-1.51M	-1.16M	-632.1K	-176.16K	-678.39K	-1.04M	-510.93K	-244K	-293.02K	-326.9K	-254.8K	-45.06K
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-30.18%	-556.84%	-23.72%	27.8%	-131.52%	-219.2%	-100.52%	-441.5%	-	-	-	-
EBITDA	-1.5M	-1.16M	-631.94K	-877.22K	-83.25K	-33.12K	3.02M	1.05M	2.63M	3.69M	10.59M	-45.06K
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-30.18%	-31.79%	-120.9%	-183.45%	-103.16%	-100.9%	-71.45%	2432.89%	-	-	-	-
D&A (Non-Cash Add-back)	1.33K	1.02K	165	0	0	0	0	0	0	0	0	0
EBIT	-750.5K	145.19K	-632.22K	-877.22K	-83.25K	-33.12K	-1.74M	1.05M	2.63M	3.69M	10.59M	-45.06K
Net Interest Income	70.06K	-3.71K	-11.47K	-27.57K	187.84K	485.6K	2.63M	-3.23M	115.55K	6.29K	2.42K	0
Interest Income	72.81K	0	0	0	187.84K	485.6K	2.63M	-3.23M	115.55K	6.29K	2.42K	0
Interest Expense	2.75K	3.71K	11.47K	27.57K	0	0	0	0	0	0	0	0
Other Income/Expense	753.05K	1.3M	-24.13M	-133.52K	449.25K	747K	2.76M	-669	2.34M	3.28M	8.56M	3
Pretax Income	-753.25K	141.47K	-24.76M	-309.68K	-62.84K	-24.49K	2.25M	-244.67K	2.04M	2.95M	8.31M	-45.06K
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-753.25K	141.47K	-24.76M	-877.22K	-62.84K	-24.49K	2.25M	766.84K	2.04M	2.95M	8.31M	-45.06K
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-632.44%	116.13%	-1200.36%	-214.39%	-103.07%	-100.83%	-72.92%	1801.93%	-	-	-	-
Net Income (Continuing)	-753.25K	141.47K	-24.76M	-877.22K	-62.84K	-24.49K	2.25M	-244.67K	2.04M	2.95M	8.31M	-45.06K
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.51	4.06	-1.85	-0.08	-0.01	-0.00	0.07	0.03	0.07	0.10	0.25	-0.00
EPS Growth %	-112.56%	4921.85%	-2785.05%	-413.01%	-110.89%	-102.1%	-72.44%	-	-	-	-	-
EPS (Basic)	-0.51	4.08	-1.85	-0.08	-0.01	-0.00	0.07	0.03	0.07	0.10	0.25	-0.00
Diluted Shares Outstanding	1.48M	276.73K	13.39M	7.69M	8.04M	11.43M	32.67M	28.54M	28.54M	28.54M	32.67M	32.75M
Basic Shares Outstanding	1.48M	276.73K	13.39M	7.69M	8.04M	11.43M	32.67M	28.54M	28.54M	28.54M	32.67M	32.75M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-